NEI Research News

Representatives from a dozen global organizations and as many countries launched a new collaboration with the National Eye Institute aimed at advancing vision research and eye heath globally

UConn School of Medicine researchers report that a small population of nerve cells exist in everyone that could be coaxed to regrow, potentially restoring sight and movement after injury.

Medical College of Georgia scientists have early evidence that targeting the bile acid receptor could provide earlier, more impactful treatments for premature babies to prevent retinopathy of prematurity.

Researchers from Johns Hopkins Medicine show that experimental drug may prevent or slow vision loss in people with diabetic retinopathy, a complication of diabetes.

Taking a daily multivitamin supplement can slow age-related memory decline, finds a large study led by researchers at Columbia University and Brigham and Women’s Hospital/Harvard.

Researchers have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

To better understand eye health care needs of the future, the National Eye Institute convened a panel of experts April 26, 2023, at the annual meeting of the Association for Research in Vision and Ophthalmology.

An inexpensive, smartphone-based camera can help doctors identify premature infants needing treatment for retinopathy of prematurity (ROP), according to a new study funded by the National Eye Institute (NEI).

Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).